Current Ratio of BioXcel Therapeutics, Inc. from 30 Sep 2018 to 31 Dec 2025
- Taxonomy & unit
- ratio: x
- Description
- The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
- Summary
-
BioXcel Therapeutics, Inc. quarterly Current Ratio in x history and change rate from 30 Sep 2018 to 31 Dec 2025.
- BioXcel Therapeutics, Inc. Current Ratio for the quarter ending 31 Dec 2025 was 1.01x, a 53% decline year-over-year.
Current Ratio, Quarterly (x)
Current Ratio, YoY Quarterly Change (%)
BioXcel Therapeutics, Inc. Quarterly Current Ratio (x)
| Period | Value | YoY Chg | Change % | Date |
|---|---|---|---|---|
| Q4 2025 | 1.01x | -1.15x | -53% | 31 Dec 2025 |
| Q3 2025 | 1.22x | -1.16x | -49% | 30 Sep 2025 |
| Q2 2025 | 1.39x | -1.13x | -45% | 30 Jun 2025 |
| Q1 2025 | 1.86x | -1.08x | -37% | 31 Mar 2025 |
| Q4 2024 | 2.16x | -1.58x | -42% | 31 Dec 2024 |
| Q3 2024 | 2.38x | -2.17x | -48% | 30 Sep 2024 |
| Q2 2024 | 2.52x | -3.83x | -60% | 30 Jun 2024 |
| Q1 2024 | 2.93x | -5.32x | -64% | 31 Mar 2024 |
| Q4 2023 | 3.74x | -5.99x | -62% | 31 Dec 2023 |
| Q3 2023 | 4.54x | -7.7x | -63% | 30 Sep 2023 |
| Q2 2023 | 6.35x | -7.72x | -55% | 30 Jun 2023 |
| Q1 2023 | 8.25x | -8.13x | -50% | 31 Mar 2023 |
| Q4 2022 | 9.72x | -7.54x | -44% | 31 Dec 2022 |
| Q3 2022 | 12.24x | -6.26x | -34% | 30 Sep 2022 |
| Q2 2022 | 14.07x | -3.43x | -20% | 30 Jun 2022 |
| Q1 2022 | 16.38x | +3.71x | +29% | 31 Mar 2022 |
| Q4 2021 | 17.26x | +6.57x | +62% | 31 Dec 2021 |
| Q3 2021 | 18.5x | +10.57x | +133% | 30 Sep 2021 |
| Q2 2021 | 17.5x | +12.46x | +247% | 30 Jun 2021 |
| Q1 2021 | 12.67x | +7.52x | +146% | 31 Mar 2021 |
| Q4 2020 | 10.69x | +6.08x | +132% | 31 Dec 2020 |
| Q3 2020 | 7.93x | +2.36x | +42% | 30 Sep 2020 |
| Q2 2020 | 5.04x | -2.41x | -32% | 30 Jun 2020 |
| Q1 2020 | 5.16x | -6.92x | -57% | 31 Mar 2020 |
| Q4 2019 | 4.61x | -11.5x | -71% | 31 Dec 2019 |
| Q3 2019 | 5.57x | -10.05x | -64% | 30 Sep 2019 |
| Q2 2019 | 7.45x | 30 Jun 2019 | ||
| Q1 2019 | 12.08x | 31 Mar 2019 | ||
| Q4 2018 | 16.11x | 31 Dec 2018 | ||
| Q3 2018 | 15.62x | 30 Sep 2018 |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.